13D/13G Filings - Brii Biosciences Limited

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
4:30 pm
Sale
2024-12-31 13G AN2 Therapeutics, Inc.
ANTX
Brii Biosciences Limited 927,201
3.100%
-121,278decrease
(-11.57%)
Filing
History
2023-07-20
4:16 pm
Purchase
2023-07-10 13G VBI VACCINES INC CDA COM
VBIVQ
Brii Biosciences Limited 2,131,447
9.990%
2,131,447increase
(New Position)
Filing
History
2023-02-13
4:45 pm
Purchase
2022-12-31 13G AN2 Therapeutics, Inc.
ANTX
Brii Biosciences Limited 1,048,479
5.400%
1,048,479increase
(New Position)
Filing
History